Sinistral portal hypertension

Splenectomy or expectant management

J. P. Loftus, D. M. Nagorney, D. Ilstrup, Allen Kunselman

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Splenectomy has been considered the treatment of choice for patients with bleeding from sinistral portal hypertension (SPH) and varices, but is controversial for asymptomatic patients. To further define the role of splenectomy for SPH, the authors compared the clinical presentations and outcomes of 25 patients treated with splenectomy with those of 12 observed patients. Clinical features were similar except for transfusions administered (60% vs. 25%, p < 0.05), hemoglobin (9.8 ± 2.2 g/dL vs. 12.5 ± 2.1 g/dL, p < 0.05), and history of prior bleeding episodes (56% vs. 8%, p < 0.05), splenectomy versus no splenectomy, respectively. At 3 years, neither survival (78% vs. 64%, p = 1.0) nor new or recurrent bleeding (16% vs. 24%, p = 0.2) differed, splenectomy versus no splenectomy, respectively. The authors conclude that in the absence of prior bleeding episodes, anemia, or severe hemorrhage, observation of patients with SPH is justified.

Original languageEnglish (US)
Pages (from-to)35-40
Number of pages6
JournalAnnals of surgery
Volume217
Issue number1
DOIs
StatePublished - Jan 1 1993

Fingerprint

Portal Hypertension
Splenectomy
Hemorrhage
Varicose Veins
Anemia
Hemoglobins
Observation
Survival

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Loftus, J. P. ; Nagorney, D. M. ; Ilstrup, D. ; Kunselman, Allen. / Sinistral portal hypertension : Splenectomy or expectant management. In: Annals of surgery. 1993 ; Vol. 217, No. 1. pp. 35-40.
@article{63939937fd554524a33a75c321777577,
title = "Sinistral portal hypertension: Splenectomy or expectant management",
abstract = "Splenectomy has been considered the treatment of choice for patients with bleeding from sinistral portal hypertension (SPH) and varices, but is controversial for asymptomatic patients. To further define the role of splenectomy for SPH, the authors compared the clinical presentations and outcomes of 25 patients treated with splenectomy with those of 12 observed patients. Clinical features were similar except for transfusions administered (60{\%} vs. 25{\%}, p < 0.05), hemoglobin (9.8 ± 2.2 g/dL vs. 12.5 ± 2.1 g/dL, p < 0.05), and history of prior bleeding episodes (56{\%} vs. 8{\%}, p < 0.05), splenectomy versus no splenectomy, respectively. At 3 years, neither survival (78{\%} vs. 64{\%}, p = 1.0) nor new or recurrent bleeding (16{\%} vs. 24{\%}, p = 0.2) differed, splenectomy versus no splenectomy, respectively. The authors conclude that in the absence of prior bleeding episodes, anemia, or severe hemorrhage, observation of patients with SPH is justified.",
author = "Loftus, {J. P.} and Nagorney, {D. M.} and D. Ilstrup and Allen Kunselman",
year = "1993",
month = "1",
day = "1",
doi = "10.1097/00000658-199301000-00007",
language = "English (US)",
volume = "217",
pages = "35--40",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Sinistral portal hypertension : Splenectomy or expectant management. / Loftus, J. P.; Nagorney, D. M.; Ilstrup, D.; Kunselman, Allen.

In: Annals of surgery, Vol. 217, No. 1, 01.01.1993, p. 35-40.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sinistral portal hypertension

T2 - Splenectomy or expectant management

AU - Loftus, J. P.

AU - Nagorney, D. M.

AU - Ilstrup, D.

AU - Kunselman, Allen

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Splenectomy has been considered the treatment of choice for patients with bleeding from sinistral portal hypertension (SPH) and varices, but is controversial for asymptomatic patients. To further define the role of splenectomy for SPH, the authors compared the clinical presentations and outcomes of 25 patients treated with splenectomy with those of 12 observed patients. Clinical features were similar except for transfusions administered (60% vs. 25%, p < 0.05), hemoglobin (9.8 ± 2.2 g/dL vs. 12.5 ± 2.1 g/dL, p < 0.05), and history of prior bleeding episodes (56% vs. 8%, p < 0.05), splenectomy versus no splenectomy, respectively. At 3 years, neither survival (78% vs. 64%, p = 1.0) nor new or recurrent bleeding (16% vs. 24%, p = 0.2) differed, splenectomy versus no splenectomy, respectively. The authors conclude that in the absence of prior bleeding episodes, anemia, or severe hemorrhage, observation of patients with SPH is justified.

AB - Splenectomy has been considered the treatment of choice for patients with bleeding from sinistral portal hypertension (SPH) and varices, but is controversial for asymptomatic patients. To further define the role of splenectomy for SPH, the authors compared the clinical presentations and outcomes of 25 patients treated with splenectomy with those of 12 observed patients. Clinical features were similar except for transfusions administered (60% vs. 25%, p < 0.05), hemoglobin (9.8 ± 2.2 g/dL vs. 12.5 ± 2.1 g/dL, p < 0.05), and history of prior bleeding episodes (56% vs. 8%, p < 0.05), splenectomy versus no splenectomy, respectively. At 3 years, neither survival (78% vs. 64%, p = 1.0) nor new or recurrent bleeding (16% vs. 24%, p = 0.2) differed, splenectomy versus no splenectomy, respectively. The authors conclude that in the absence of prior bleeding episodes, anemia, or severe hemorrhage, observation of patients with SPH is justified.

UR - http://www.scopus.com/inward/record.url?scp=0027449977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027449977&partnerID=8YFLogxK

U2 - 10.1097/00000658-199301000-00007

DO - 10.1097/00000658-199301000-00007

M3 - Article

VL - 217

SP - 35

EP - 40

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 1

ER -